Education
About Us
Working with TipRanks
Follow Us
Trulieve Cannabis (TCNNF)
OTHER OTC:TCNNF
TCNNF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.66 - $14.50
Previous CloseN/A
Volume237.15K
Average Volume (3M)477.68K
Market Cap
$715.57M
Enterprise Value$3.81B
Total Cash (Recent Filing)$238.80M
Total Debt (Recent Filing)$824.46M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
May 08, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.88
Shares Outstanding167,779,560
10 Day Avg. Volume620,482
30 Day Avg. Volume477,678
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.63
Price to Cash Flow (P/CF)6.10
P/FCF Ratio1.90
Enterprise Value/Market Cap5.33
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.33
Enterprise Value/Ebitda13.48
Forecast
1Y Price Target
$14.25Price Target Upside275.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
Trulieve Cannabis News
PremiumCompany Announcements
Trulieve Expands Distribution of Onward THC Beverages in Florida
PremiumCompany Announcements
Trulieve Expands with New Dispensary in North Miami Beach
PremiumCompany Announcements
Trulieve Cannabis Reports Strong 2024 Financial Results
PremiumCompany Announcements
Trulieve Cannabis Reports Strong Earnings Amidst Challenges
PremiumCompany Announcements
Trulieve Launches Onward: A Premium THC Beverage Line---
Bulls Say, Bears Say
Bulls Say
Cash ReservesSizable cash pile creates optionality: With $356 million of cash on hand, Trulieve has plenty of firepower to invest in growth catalysts across the board.
Financial PerformanceTrulieve reported strong gross margins that led to EBITDA above expectations.
Future ProspectsStrong execution allowed Trulieve to exceed both top and bottom-line expectations for the quarter and introduce Q3/24 revenue guidance that’s in line with consensus expectations while also boosting operating cash flow guidance for the year to >$250 million.
Investment AttractivenessGiven Trulieve’s healthy financial position, access to capital, and best-in-class profitability metrics, the stock is attractive for investors looking for cannabis exposure to a high-quality operator.
Market PositionTrulieve is best positioned to benefit with the largest Florida footprint if Amendment 3 passes.
Bears Say
Market VolatilityVolatility in the stock is likely due to the Amendment 3 vote occurring in Florida.
---
Ownership Overview
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
TCNNF FAQ
What was Trulieve Cannabis’s price range in the past 12 months?
Trulieve Cannabis lowest stock price was $3.66 and its highest was $14.50 in the past 12 months.
What is Trulieve Cannabis’s market cap?
Trulieve Cannabis’s market cap is $715.57M.
When is Trulieve Cannabis’s upcoming earnings report date?
Trulieve Cannabis’s upcoming earnings report date is May 08, 2025 which is in 41 days.
How were Trulieve Cannabis’s earnings last quarter?
Trulieve Cannabis released its earnings results on Feb 27, 2025. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.22 by -$0.09.
Is Trulieve Cannabis overvalued?
According to Wall Street analysts Trulieve Cannabis’s price is currently Undervalued.
Does Trulieve Cannabis pay dividends?
Trulieve Cannabis does not currently pay dividends.
What is Trulieve Cannabis’s EPS estimate?
Trulieve Cannabis’s EPS estimate is -0.08.
How many shares outstanding does Trulieve Cannabis have?
Trulieve Cannabis has 167,779,560 shares outstanding.
What happened to Trulieve Cannabis’s price movement after its last earnings report?
Trulieve Cannabis reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.22. Following the earnings report the stock price went up 5.569%.
Which hedge fund is a major shareholder of Trulieve Cannabis?
Currently, no hedge funds are holding shares in TCNNF
---
Trulieve Cannabis Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.25 (275.99% Upside)
$14.25 (275.99% Upside)
Blogger Sentiment
Bullish
TCNNF Sentiment 93%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $46.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.07%
12-Months-Change
Fundamentals
Return on Equity
-12.12%
Trailing 12-Months
Asset Growth
5.63%
Trailing 12-Months
Company Description
Trulieve Cannabis
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
---
TCNNF Company Deck
---
TCNNF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Trulieve showcased strong financial performance with revenue, gross margin, and adjusted EBITDA improvements. Despite a net loss and increased SG&A expenses, the company's strategic initiatives and expansion efforts contributed positively. The setback in Florida's adult-use legalization was notable, but overall, the highlights outweigh the lowlights.Read More>---
TCNNF Stock 12 Month Forecast
Average Price Target
$14.25
▲(275.99% Upside)
Technical Analysis
TILT Holdings Inc
―
Curaleaf Holdings
―
Green Thumb Industries
―
Cresco Labs
―
Verano Holdings
―
Best Analysts Covering TCNNF
1 Year
1 Year Success Rate
7/22 ratings generated profit
1 Year Average Return
+2.83%
reiterated a buy rating 29 days ago
Copying Andrew Semple's trades and holding each position for 1 Year would result in 31.82% of your transactions generating a profit, with an average return of +2.83% per trade.
---